Short Bowel Syndrome: Clinical Trials

11 trials for Short Bowel Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 unknown, 1 terminated, 1 withdrawn. 11 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 111Completed 7, Unknown 2, Terminated 1, Withdrawn 1
Phase 25Completed 2, Terminated 1, Unknown 1, Withdrawn 1

Follow Short Bowel Syndrome: new trials by email Literature Review of Short Bowel Syndrome trials Research Report on Short Bowel Syndrome

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of PJ009 in Healthy Adult Volunteers
PJ009, Placebo - Short Bowel Syndrome
Phase 1CompletedChongqing Peg-Bio Biopharm Co., Ltd.242023-02-282024-07-29
Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome
Amoxicillin, Levofloxacin, Ofloxacin - Short Bowel Syndrome, Infection, Bacterial
Phase 1UnknownCentral Hospital, Nancy, France102022-12-092024-08-29
Study of NST-6179 in Healthy Subjects
NST 6179, Placebo - Short Bowel Syndrome, Parenteral Nutrition Associated Liver Disease
Phase 1CompletedNorthSea Therapeutics B.V.702021-11-112024-06-24
Proof of Concept Study in Patients With Short Bowel Syndrome
NM-002 - Short Bowel Syndrome
Phase 1 / Phase 2Unknown9 Meters Biopharma, Inc.122020-06-232020-11-20
Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support
FE203799 GLP-2 analogue, FE203799 Placebo GLP-2 analogue - Short Bowel Syndrome
Phase 1 / Phase 2CompletedGlyPharma Therapeutics82018-05-082024-10-26
Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency
FE203799 - SBS - Short Bowel Syndrome
Phase 1 / Phase 2CompletedGlyPharma Therapeutics82018-05-022024-10-24
Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
Glucagon-Like Peptide 2, Glucagon like peptide-2 - Intestinal Failure, Short Bowel Syndrome
Phase 1 / Phase 2TerminatedAlberta Children's Hospital132012-01-012014-12-23
Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
Lovaza (omega-3-acid ethyl ester), Corn oil - Liver Disease, Short Bowel Syndrome
Phase 1 / Phase 2WithdrawnBoston Children's Hospital2011-01-012017-06-22
Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers
Teduglutide - Healthy
Phase 1CompletedNycomed722009-11-012012-05-07
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome
Oral, live, pentavalent rotavirus vaccine; RotaTeq(R) - Short Bowel Syndrome
Phase 1CompletedChildren's Hospital of Michigan82009-07-012014-06-13
Cholestasis Prevention: Efficacy of IV Fish Oil
Omegaven, Intralipid - Cholestasis, Parenteral Nutrition
Phase 1CompletedBoston Children's Hospital192007-07-012020-12-03

Narrower conditions

Bacterial Infections (1)  ·  Cholestasis (1)  ·  Enterocolitis, Necrotizing (1)  ·  Gastroschisis (1)  ·  Hyperphagia (1)  ·  Infant Nutrition Disorders (1)  ·  Intestinal Atresia (1)  ·  Intestinal Failure (1)  ·  Liver Diseases (1)  ·  Malnutrition (1)

Broader conditions

Digestive System Diseases (11)  ·  Gastrointestinal Diseases (11)  ·  Intestinal Diseases (11)  ·  Malabsorption Syndromes (11)  ·  Pathologic Processes (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Postoperative Complications (11)  ·  Bacterial Infections and Mycoses (1)  ·  Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Abnormalities (1)  ·  Enterocolitis (1)  ·  Gastroenteritis (1)

Interventions

Amoxicillin (1)  ·  Corn Oil (1)  ·  Fish Oils (1)  ·  Glucagon-Like Peptide 2 (1)  ·  Levofloxacin (1)  ·  Ofloxacin (1)  ·  Omacor (1)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (1)  ·  fish oil triglycerides (1)  ·  soybean oil, phospholipid emulsion (1)  ·  teduglutide (1)

Sponsors

Boston Children's Hospital (2)  ·  GlyPharma Therapeutics (2)  ·  9 Meters Biopharma, Inc. (1)  ·  Alberta Children's Hospital (1)  ·  Central Hospital, Nancy, France (1)  ·  Children's Hospital of Michigan (1)  ·  Chongqing Peg-Bio Biopharm Co., Ltd. (1)  ·  NorthSea Therapeutics B.V. (1)  ·  Nycomed (1)

Countries

United States (4)  ·  Denmark (2)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Tomasz Masior (2)  ·  David Sigalet, MD PhD (1)  ·  Eric J McGrath, MD (1)  ·  Mark Puder, MD, PhD (1)  ·  Ruigang Hou (1)  ·  Tom Jaksic, MD, PhD (1)

Results publications

PMID 15530127, PMID 1559306, PMID 20094812, PMID 2292168, PMID 23770843, PMID 24667978, PMID 29127863, PMID 34287970, PMID 6699766, PMID 7619677, PMID 7924123, PMID 9724482